Found 49 matching trials
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes
PHASE3The objective of the current study is to investigate the efficacy, safety a...
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors
PHASE4Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Location
Kurume University Hospital
Effects of Linagliptin on Endothelial Function
PHASE4This study is planned to evaluate if linagliptin can improve endothelial fu...
Location
Medical University of Graz, Department for Internal Medicine
Linagliptin in Post-renal Transplantation
N/APost-renal transplanted patients frequently present hyperglycemia immediate...
Location
Multiple Locations
The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects
PHASE4This is a single center, prospective randomized double blind, parallel and ...
Location
ECMC Ambulatory Center, 3rd Floor
The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
PHASE2The objective of this study is to investigate the effect of BI 1356 on 24-h...
Location
1218.37.49003 Boehringer Ingelheim Investigational Site
The Microvascular Function of GLP-1 and Its Analogues
NAIncretins have become a successful drug target in the repertoire of medicat...
Location
Diabetes and Vascular Center
A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers
PHASE4Diabetes mellitus is a common disease with much impact on human's health an...
Location
Multiple Locations
Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naĆÆve Type 2 Patients
PHASE3Reduced factorial design study with 24 week randomized treatment of initial...
Location
1288.18.86001 Boehringer Ingelheim Investigational Site
Efficacy and Safety of Empagliflozin in NODAT
PHASE4This is an open label, randomized controlled study. We'd like to access the...
Location
Department of nephrology, endocrinology and kidney transplantation , Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine